Outer Membrane Vesicle Induction and Isolation for Vaccine Development
- PMID: 33613498
- PMCID: PMC7889600
- DOI: 10.3389/fmicb.2021.629090
Outer Membrane Vesicle Induction and Isolation for Vaccine Development
Abstract
Gram-negative bacteria release vesicular structures from their outer membrane, so called outer membrane vesicles (OMVs). OMVs have a variety of functions such as waste disposal, communication, and antigen or toxin delivery. These vesicles are the promising structures for vaccine development since OMVs carry many surface antigens that are identical to the bacterial surface. However, isolation is often difficult and results in low yields. Several methods to enhance OMV yield exist, but these do affect the resulting OMVs. In this review, our current knowledge about OMVs will be presented. Different methods to induce OMVs will be reviewed and their advantages and disadvantages will be discussed. The effects of the induction and isolation methods used in several immunological studies on OMVs will be compared. Finally, the challenges for OMV-based vaccine development will be examined and one example of a successful OMV-based vaccine will be presented.
Keywords: Bordetella pertussis; Neisseria meningitidis; host defense peptides; induction; isolation; outer membrane vesicles; vaccine development.
Copyright © 2021 Balhuizen, Veldhuizen and Haagsman.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
High dissolved oxygen tension triggers outer membrane vesicle formation by Neisseria meningitidis.Microb Cell Fact. 2018 Oct 3;17(1):157. doi: 10.1186/s12934-018-1007-7. Microb Cell Fact. 2018. PMID: 30285743 Free PMC article.
-
Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.Vaccine. 2019 Nov 8;37(47):6978-6986. doi: 10.1016/j.vaccine.2019.01.076. Epub 2019 Aug 2. Vaccine. 2019. PMID: 31383485
-
Outer Membrane Vesicles of Bordetella pertussis Encapsulated into Sodium Alginate Nanoparticles as Novel Vaccine Delivery System.Curr Pharm Des. 2021;27(42):4341-4354. doi: 10.2174/1381612827666210907154715. Curr Pharm Des. 2021. PMID: 34493192
-
Immune Responses Elicited by Outer Membrane Vesicles of Gram-Negative Bacteria: Important Players in Vaccine Development.Life (Basel). 2024 Dec 2;14(12):1584. doi: 10.3390/life14121584. Life (Basel). 2024. PMID: 39768292 Free PMC article. Review.
-
Bordetella pertussis and outer membrane vesicles.Pathog Glob Health. 2023 Jun;117(4):342-355. doi: 10.1080/20477724.2022.2117937. Epub 2022 Sep 1. Pathog Glob Health. 2023. PMID: 36047634 Free PMC article. Review.
Cited by
-
Mycobacterium abscessus extracellular vesicles increase mycobacterial resistance to clarithromycin in vitro.Proteomics. 2024 May;24(10):e2300332. doi: 10.1002/pmic.202300332. Epub 2024 Jan 18. Proteomics. 2024. PMID: 38238893 Free PMC article.
-
Bacterial Extracellular Vesicles in Gastrointestinal Tract Cancer: An Unexplored Territory.Cancers (Basel). 2021 Oct 29;13(21):5450. doi: 10.3390/cancers13215450. Cancers (Basel). 2021. PMID: 34771614 Free PMC article. Review.
-
Application of Stem Cell-Derived Extracellular Vesicles as an Innovative Theranostics in Microbial Diseases.Front Microbiol. 2021 Nov 30;12:785856. doi: 10.3389/fmicb.2021.785856. eCollection 2021. Front Microbiol. 2021. PMID: 34917064 Free PMC article. Review.
-
Optimization of methods for isolation and purification of outer membrane vesicles (OMVs) from Neisseria lactamica.Appl Microbiol Biotechnol. 2025 Apr 7;109(1):82. doi: 10.1007/s00253-025-13460-y. Appl Microbiol Biotechnol. 2025. PMID: 40192813 Free PMC article.
-
Bacterial extracellular vesicle applications in cancer immunotherapy.Bioact Mater. 2022 Oct 31;22:551-566. doi: 10.1016/j.bioactmat.2022.10.024. eCollection 2023 Apr. Bioact Mater. 2022. PMID: 36382022 Free PMC article.
References
-
- Asensio C. J. A., Gaillard M. E., Moreno G., Bottero D., Zurita E., Rumbo M., et al. . (2011). Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid a deacylase PagL as a novel acellular vaccine candidate. Vaccine 29, 1649–1656. 10.1016/j.vaccine.2010.12.068, PMID: - DOI - PubMed
-
- Balhuizen M. D., Versluis C. M., van Harten R. M., de Jonge E. F., Brouwers J. F., van de Lest C. H. A., et al. (2021). PMAP-36 reduces the innate immune response induced by Bordetella bronchiseptica-derived outer membrane vesicles. Curr. Res. Microbial. Sci. 2:100010. 10.1016/j.crmicr.2020.100010 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources